Safety Pharmacology for the 21st Century – new technologies and approaches supporting safety and predictivity within drug discovery and development

Helen Prior
Programme Manager, Drug Development,National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs), London, United Kingdom ,

Todd Wisialowski
Associate Research Fellow,Pfizer Inc, Groton, The United States of America , 3 0 President,Safety Pharmacology Society, Groton, The United States of America

Advances in Safety Pharmacology for improved risk assessment and translation of cardiovascular and CNS adverse events
Mr Todd Wisialowski
SPS President (2022), Pfizer, Groton, The United States of America
2022 President, Safety Pharmacology Society, Groton, The United States of America

Innovative models for in vitro detection of seizure
Dr Kimberley Rockley
Research Fellow, ApconiX, Alderley Edge, United Kingdom

Oral communication speaker to be confirmed in 2023.

Use of computational approaches to identify cardiotoxicity risk
Speaker to be confirmed
To be confirmed

Integration of multiple endpoints into the same animal model or toxicology studies
Dr Francesca Pibiri
J&J Belgium, Beers, Belgium